EFG Asset Management North America Corp. Grows Holdings in Axon Enterprise, Inc $AXON

Key Points

• EFG Asset Management North America Corp. increased its stake in Axon Enterprise, acquiring an additional 2,206 shares and holding a total of 10,783 shares, representing 0.9% of its portfolio.
• Multiple institutional investors have also increased their stakes in Axon Enterprise, with TCTC Holdings LLC boosting its holdings by 75.0% in the same quarter.
• Analysts have positively rated Axon Enterprise, with a consensus price target of $837.69, and reports indicate projected earnings growth for the current fiscal year.

EFG Asset Management North America Corp. boosted its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 25.7% in the first quarter, according to its most recent filing with the SEC. The firm owned 10,783 shares of the biotechnology company's stock after acquiring an additional 2,206 shares during the period. Axon Enterprise accounts for 0.9% of EFG Asset Management North America Corp.'s portfolio, making the stock its 20th largest position. EFG Asset Management North America Corp.'s holdings in Axon Enterprise were worth $5,671,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of the business. LaSalle St. Investment Advisors LLC grew its holdings in Axon Enterprise by 2.1% during the 1st quarter. LaSalle St. Investment Advisors LLC now owns 777 shares of the biotechnology company's stock worth $408,000 after acquiring an additional 16 shares during the period. Smartleaf Asset Management LLC grew its holdings in Axon Enterprise by 5.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 379 shares of the biotechnology company's stock worth $203,000 after acquiring an additional 18 shares during the period. Pinion Investment Advisors LLC grew its holdings in shares of Axon Enterprise by 3.0% in the 1st quarter. Pinion Investment Advisors LLC now owns 649 shares of the biotechnology company's stock valued at $341,000 after buying an additional 19 shares during the period. Kentucky Retirement Systems grew its holdings in shares of Axon Enterprise by 0.4% in the 1st quarter. Kentucky Retirement Systems now owns 4,953 shares of the biotechnology company's stock valued at $2,605,000 after buying an additional 19 shares during the period. Finally, WCM Investment Management LLC grew its holdings in shares of Axon Enterprise by 0.8% in the 1st quarter. WCM Investment Management LLC now owns 2,441 shares of the biotechnology company's stock valued at $1,306,000 after buying an additional 19 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Insider Transactions at Axon Enterprise

In related news, insider Jeffrey C. Kunins sold 7,891 shares of the business's stock in a transaction dated Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the transaction, the insider directly owned 144,538 shares in the company, valued at approximately $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Hadi Partovi purchased 1,358 shares of the business's stock in a transaction that occurred on Wednesday, August 13th. The shares were purchased at an average price of $740.00 per share, for a total transaction of $1,004,920.00. Following the completion of the acquisition, the director owned 237,938 shares of the company's stock, valued at $176,074,120. The trade was a 0.57% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders sold 34,865 shares of company stock worth $26,926,433. Corporate insiders own 5.70% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on AXON. Needham & Company LLC set a $870.00 price target on shares of Axon Enterprise and gave the stock a "buy" rating in a research report on Tuesday, August 5th. UBS Group reaffirmed a "neutral" rating and issued a $840.00 target price (up from $820.00) on shares of Axon Enterprise in a report on Tuesday, August 5th. Bank of America upped their target price on shares of Axon Enterprise from $895.00 to $1,000.00 and gave the company a "buy" rating in a report on Wednesday, August 6th. Morgan Stanley set a $885.00 target price on shares of Axon Enterprise and gave the company an "overweight" rating in a report on Friday, July 11th. Finally, JPMorgan Chase & Co. upped their target price on shares of Axon Enterprise from $730.00 to $850.00 and gave the company an "overweight" rating in a report on Thursday, July 17th. Thirteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to data from MarketBeat.com, Axon Enterprise has a consensus rating of "Moderate Buy" and a consensus target price of $837.69.

Axon Enterprise Stock Performance

AXON traded down $12.37 on Tuesday, reaching $728.24. The company had a trading volume of 159,966 shares, compared to its average volume of 689,122. The company's fifty day moving average is $764.18 and its 200 day moving average is $682.14. Axon Enterprise, Inc has a fifty-two week low of $353.91 and a fifty-two week high of $885.91. The company has a debt-to-equity ratio of 0.63, a quick ratio of 2.71 and a current ratio of 2.95. The stock has a market cap of $57.17 billion, a P/E ratio of 179.81, a P/E/G ratio of 26.73 and a beta of 1.40.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.54 by $0.58. The firm had revenue of $668.54 million during the quarter, compared to the consensus estimate of $641.77 million. Axon Enterprise had a net margin of 13.64% and a return on equity of 6.80%. The company's revenue for the quarter was up 32.6% on a year-over-year basis. During the same quarter last year, the firm earned $1.20 earnings per share. Axon Enterprise has set its FY 2025 guidance at EPS. As a group, analysts predict that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.